NORGESTREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norgestrel, and when can generic versions of Norgestrel launch?
Norgestrel is a drug marketed by Mylan Labs Ltd and is included in two NDAs.
The generic ingredient in NORGESTREL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for NORGESTREL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NORGESTREL at DailyMed |
Recent Clinical Trials for NORGESTREL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sohag University | Early Phase 1 |
| Health Decisions | Phase 2 |
| HRA Pharma | Phase 2 |
Medical Subject Heading (MeSH) Categories for NORGESTREL
US Patents and Regulatory Information for NORGESTREL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | NORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 201828-001 | Jun 21, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Labs Ltd | NORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 202875-001 | May 8, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
